GSK plc - SPONSORED ADR (GSK)

Historical Portfolio Holders from Q1 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
303M
Holdings value Q3 2024
$12.4B
Value change Q3 2024
-$140M
Grand Portfolio weight change Q3 2024
0%
Number of holders
871
Number of buys Q3 2024
376
Number of sells Q3 2024
-377
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 303M $12.4B -$140M $40.88 880
2024 Q2 309M $11.9B -$23.8M $38.50 867
2024 Q1 309M $13.2B +$832M $42.87 890
2023 Q4 289M $10.7B +$179M $37.06 868
2023 Q3 284M $10.3B +$265M $36.25 824
2023 Q2 276M $9.85B +$194M $35.64 804
2023 Q1 270M $9.59B -$209M $35.58 784
2022 Q4 276M $9.7B +$517M $35.14 783
2022 Q3 264M $7.78B +$7.65B $29.43 694
2022 Q2 4.25M $185M +$183M $43.53 65
2022 Q1 51.7K $2.26M -$356K $43.56 5
2021 Q4 59.8K $2.65M -$140K $44.10 6
2021 Q3 16.9K $653K +$7.79K $38.21 5
2021 Q2 16.7K $672K -$30.2K $39.82 5
2021 Q1 17.4K $632K +$393K $35.69 5
2020 Q4 6.68K $246K -$29.1K $36.80 3
2020 Q3 7.47K $280K -$18.5K $37.64 3
2020 Q2 7.97K $325K -$17.3K $40.79 3
2020 Q1 8.39K $316K -$7.5K $37.89 3
2019 Q4 8.59K $404K +$47.00 $46.99 3
2019 Q3 6.01K $257K +$42.70 $42.68 2
2019 Q2 6.01K $241K +$280 $40.02 2
2019 Q1 6K $251K -$58.5K $41.79 2
2018 Q4 7.4K $283K -$24K $38.21 2
2018 Q3 8.03K $323K -$357K $40.17 2
2018 Q2 16.9K $682K +$80.60 $40.31 2
2018 Q1 16.9K $661K +$10.2K $39.07 2
2017 Q4 16.7K $591K -$47.3K $35.47 2
2017 Q3 18K $731K -$110K $40.60 2
2017 Q2 20.7K $893K $0 $43.12 2
2017 Q1 20.7K $873K $0 $42.16 2
2016 Q4 20.7K $797K +$182K $38.51 2
2016 Q3 16K $689K +$10.8K $43.13 2
2016 Q2 15.7K $681K -$56.3K $43.34 2
2016 Q1 17K $690K $0 $40.55 2